Mental Health

Studying a new way to treat schizophrenia

Dr. Anil Malhotra will lead a new double-blind, randomized clinical trial that will study if rTMS improves social cognitive performance of people living with schizophrenia over the course of five years.

Thanks to a $3.4 million grant from the Wellcome Trust, researchers at Northwell’s Feinstein Institutes for Medical Research are studying a new nonpharmacological way to treat major mental health disorders such as schizophrenia spectrum disorders and psychosis. 

Support Feinstein Institutes for Medical Research

$500 $250 $100 $50 Other
Give Now
Related stories
Mental Health
The art of healing depression
Artist Corey Paige donated a mural to South Oaks Hospital to help lift the spirits of kids facing depression and other…
Research
Leveraging AI and machine learning to enhance patient care
Scott and Debby Rechler’s generous gift fuels the promise of proactive care.
Mental Health
Shining a light on behavioral health at Lenox Hill Hospital
Arlene and Daniel Fisher's $1 million bequest will fill critical gaps in care.

Support Northwell Health

$500 $250 $100 $50 Other
Give Now

We are Northwell Health, a nonprofit organization supported by the people and communities we serve.

Northwell Health Foundation
2000 Marcus Avenue | New Hyde Park, NY 11042

© Copyright 2025 Northwell Health. As an official 501(c)(3) nonprofit organization, your gift is tax-deductible as allowed by law.

Visit Northwell Health